Author information
1University of Texas Health Science Center, San Antonio, Texas, USA.
2Medical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
3University of Texas Health Science Center, Houston, Texas, USA.
4University Health, San Antonio, Texas, USA.
5UT Southwestern Medical Center, Dallas, Texas, USA.
6Parkland Health, Dallas, Texas, USA.
Abstract
Hepatitis B virus (HBV) increases morbidity and mortality among people with HIV (PWH). We retrospectively analyzed HBV incidence among 5785 PWH. Fourteen had newly positive hepatitis B s antigen (mean 5.2 person-years of follow-up, 46.4/100 000 infections/year). These data show gaps in HBV vaccination and in the preventative efficacy of HBV-specific antiretroviral therapy.
Stay Informed!
